A new blood test based on 10 "biomarker" proteins will make it possible to test new treatments at an early stage of Alzheimer's progression.
Writing in the journal Alzheimer's & Dementia, researchers from King's College London describe how they investigated 26 proteins previously associated with Alzheimer's disease.
They analysed blood samples from 476 confirmed Alzheimer's patients, 220 individuals with "mild cognitive impairment" (MCI) who experienced occasional memory loss, and 450 healthy elderly people.
In the vast majority of cases, memory lapses do not lead to Alzheimer's. But the researchers identified 10 blood proteins that appeared in 87% of MCI patients diagnosed with the disease within a year.
More top news
Molly Smith, 5, won £500 after her accidental selfie with a snowman caught the attention of competition judges.
Harry Street, formerly Barry Williams, shot dead five people in a spree across the West Midlands in 1978.
The Interview, the Sony film about a fictional plot to assassinate North Korean leader Kim Jong Un, has made more than $15m in online sales.